0001181431-12-064438.txt : 20121213
0001181431-12-064438.hdr.sgml : 20121213
20121213153043
ACCESSION NUMBER: 0001181431-12-064438
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121212
FILED AS OF DATE: 20121213
DATE AS OF CHANGE: 20121213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Martin Tami Tillotson
CENTRAL INDEX KEY: 0001539494
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35518
FILM NUMBER: 121262044
MAIL ADDRESS:
STREET 1: C/O SUPERNUS PHARMACEUTICALS, INC.
STREET 2: 1550 EAST GUDE DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001356576
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 1550 E GUDE DR
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-838-2500
MAIL ADDRESS:
STREET 1: 1550 E GUDE DR
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
rrd363472.xml
X0306
4
2012-12-12
0
0001356576
SUPERNUS PHARMACEUTICALS INC
SUPN
0001539494
Martin Tami Tillotson
C/O SUPERNUS PHARMACEUTICALS, INC.
1550 EAST GUDE DRIVE
ROCKVILLE
MD
20850
0
1
0
0
VP of Regulatory Affairs
Common Stock
2012-12-12
4
M
0
37500
1.6
A
40000
D
Common Stock
2012-12-12
4
M
0
1250
3.36
A
41250
D
Common Stock
2012-12-12
4
M
0
9375
2.56
A
50625
D
Employee Stock Option (right to buy)
1.60
2012-12-12
4
M
0
37500
0
D
2018-07-16
Common Stock
37500
0
D
Employee Stock Option (right to buy)
3.36
2012-12-12
4
M
0
1250
0
D
2020-02-10
Common Stock
1250
1250
D
Employee Stock Option (right to buy)
2.56
2012-12-12
4
M
0
9375
0
D
2020-11-02
Common Stock
9375
28125
D
25% of the shares subject to the option vested on each of 7/16/2009, 7/16/2010, 7/16/2011 and 7/16/2012.
25% of the shares subject to the option vested on each of 2/10/2011 and 2/10/2012, and the remaining shares subject to the option will vest in approximately equal installments on 2/10/13 and 2/10/14.
25% of the shares subject to the option vested on 11/2/2011, and the remaining shares subject to the option will vest in approximately equal quarterly installments over the following three years.
/s/ Gregory S. Patrick, as attorney-in-fact
2012-12-13